...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
Great post Bear thanks. 26 weeks Possibly? Very exciting. Correct me if I'm wrong but didn't RVX reach a PPS of $29 during a PII trial? And we'll have a pIII trial going on at the same time. Future looks good. :)
Share
New Message
Please login to post a reply